WCMC logo
PMKB
  • Login
AKT2

Interpretations

By Variant(s)

AKT2 copy number gain

AKT2 copy number loss

AKT2 any mutation

By Tumor

  • Acinar Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Acinic Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Acute Myeloid Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Adenocarcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Adenoid Cystic Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Adenosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Ameloblastic Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Anaplastic Large Cell Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Angioimmunoblastic T-Cell Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Angiomatoid Fibrous Histiocytoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Angiomatosis
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Angiomyolipoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Angiosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Astrocytoma, Anaplastic
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Atypical Chronic Myeloid Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • B Lymphoblastic Leukemia/Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Basal Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Burkitt Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Carcinoid Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Carcinosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Cholangiocarcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Chondrosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Chordoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Choriocarcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Chromophobe Renal Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Chronic Lymphocytic Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Chronic Myeloid Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Chronic Myelomonocytic Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Chronic Neutrophilic Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Classical Hodgkin Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Clear Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Clear Cell Renal Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Craniopharyngioma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Dermatofibrosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Desmoplastic Small Round Cell Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Diffuse Large B Cell Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Ductal Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Ependymoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Essential Thrombocythemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Ewing Sarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Fibromatosis
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Follicular Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Follicular Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Gastrointestinal Stromal Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Germ Cell Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Giant Cell Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Glioblastoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Glomus Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Granular Cell Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Hairy Cell Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Hemangioendothelioma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Hepatocellular Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Histiocytic and Dendritic Cell Neoplasms
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Invasive Ductal Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Kaposi Sarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Langerhans Cell Histiocytosis
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Leiomyoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Leiomyosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Lipoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Liposarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Lobular Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Lymphoplasmacytic Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Malignant Mullerian Mixed Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mantle Cell Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Marginal Zone B Cell Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mast Cell Neoplasm
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • MDS with Ring Sideroblasts
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Medullary Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Medulloblastoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Melanoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Meningioma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Merkel Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mesothelioma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mucinous Tumors of Appendix
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mucinous Tumors of Ovary
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mucoepidermoid Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Myelodysplastic Syndrome
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Myeloproliferative Neoplasm
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Myxofibrosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Nasopharyngeal Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Neuroblastoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Neuroendocrine Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Neuroendocrine Neoplasm
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • NK Cell Lymphoproliferative Disorder
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • NLPHL
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Non-Small Cell Lung Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Oligodendroglioma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Osteosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Papillary Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Papillary Renal Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Peripheral T Cell Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Pheochromocytoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Plasma Cell Disorder
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Polycythemia Vera
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Post-Transplant Lymphoproliferative Disorder
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Primary Myelofibrosis
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Primitive Neuroectodermal Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Renal Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Reninoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Retinoblastoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Rhabdomyosarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Sarcoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Schwannoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Serous Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Sex Cord Stromal Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Small Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Solid Pseudopapillary Tumor of Pancreas
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Spindle Cell Neoplasm
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Squamous Cell Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • T Cell Lymphoproliferative Disorder
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • T Lymphoblastic Leukemia/Lymphoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • T-Cell LGL Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Thymic Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Thymoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Urothelial Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Tumors of Peripheral Nerves
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Unknown
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Wilms Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Ependymoma, Anaplastic
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Astrocytoma, Pilocytic
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Ganglioglioma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Neuroepithelial Neoplasm, NOS
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Pleomorphic Carcinoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Solitary Fibrous Tumor
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Neuroepithelial neoplasm, high grade
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Leukocytosis
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Thrombocytosis
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Monocytosis
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Cytopenia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Other Acute Leukemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Astrocytoma, NOS
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Acute Leukemia of Unspecified Cell Type
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Anemia, Unspecified
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Astrocytoma, Diffusely Infiltrating
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Diffuse Midline Glioma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Infiltrating Glioma, NOS
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Intraductal Papillary Mucinous Neoplasm (IPMN)
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Leukopenia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Lymphadenopathy
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Lymphocytosis, Symptomatic
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Monoclonal Gammopathy
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mucinous or Serous Cystic Neoplasms of Pancreas
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Mycosis Fungoides, Unspecified Site
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Oligodendroglioma, Anaplastic
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Pleomorphic Xanthoastrocytoma
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Rash and Other Nonspecific Skin Eruption
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Thrombocytopenia, Unspecified
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Eosinophilia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Myelodysplastic/Myeloproliferative Neoplasm
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Myeloid Neoplasm
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Polycythemia
    • AKT2 copy number gain, AKT2 copy number loss
    • AKT2 any mutation
  • Information
  • View History
  • Suggested Revisions
Interpretation 429
Variant(s)AKT2 copy number gain
AKT2 copy number loss
Tumor(s)Acinar Cell Carcinoma
Acinic Cell Carcinoma
Acute Myeloid Leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adenosarcoma
Ameloblastic Tumor
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-Cell Lymphoma
Angiomatoid Fibrous Histiocytoma
Angiomatosis
Angiomyolipoma
Angiosarcoma
Astrocytoma, Anaplastic
Atypical Chronic Myeloid Leukemia
B Lymphoblastic Leukemia/Lymphoma
Basal Cell Carcinoma
Burkitt Lymphoma
Carcinoid Tumor
Carcinoma
Carcinosarcoma
Cholangiocarcinoma
Chondrosarcoma
Chordoma
Choriocarcinoma
Chromophobe Renal Cell Carcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Chronic Neutrophilic Leukemia
Classical Hodgkin Lymphoma
Clear Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Craniopharyngioma
Dermatofibrosarcoma
Desmoplastic Small Round Cell Tumor
Diffuse Large B Cell Lymphoma
Ductal Carcinoma
Ependymoma
Essential Thrombocythemia
Ewing Sarcoma
Fibromatosis
Follicular Carcinoma
Follicular Lymphoma
Gastrointestinal Stromal Tumor
Germ Cell Tumor
Giant Cell Tumor
Glioblastoma
Glomus Tumor
Granular Cell Tumor
Hairy Cell Leukemia
Hemangioendothelioma
Hepatocellular Carcinoma
Histiocytic and Dendritic Cell Neoplasms
Invasive Ductal Carcinoma
Kaposi Sarcoma
Langerhans Cell Histiocytosis
Leiomyoma
Leiomyosarcoma
Lipoma
Liposarcoma
Lobular Carcinoma
Lymphoplasmacytic Lymphoma
Malignant Mullerian Mixed Tumor
Mantle Cell Lymphoma
Marginal Zone B Cell Lymphoma
Mast Cell Neoplasm
MDS with Ring Sideroblasts
Medullary Carcinoma
Medulloblastoma
Melanoma
Meningioma
Merkel Cell Carcinoma
Mesothelioma
Mucinous Tumors of Appendix
Mucinous Tumors of Ovary
Mucoepidermoid Carcinoma
Myelodysplastic Syndrome
Myeloproliferative Neoplasm
Myxofibrosarcoma
Nasopharyngeal Carcinoma
Neuroblastoma
Neuroendocrine Carcinoma
Neuroendocrine Neoplasm
NK Cell Lymphoproliferative Disorder
NLPHL
Non-Small Cell Lung Carcinoma
Oligodendroglioma
Osteosarcoma
Papillary Carcinoma
Papillary Renal Cell Carcinoma
Peripheral T Cell Lymphoma
Pheochromocytoma
Plasma Cell Disorder
Polycythemia Vera
Post-Transplant Lymphoproliferative Disorder
Primary Myelofibrosis
Primitive Neuroectodermal Tumor
Renal Cell Carcinoma
Reninoma
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Schwannoma
Serous Carcinoma
Sex Cord Stromal Tumor
Small Cell Carcinoma
Solid Pseudopapillary Tumor of Pancreas
Spindle Cell Neoplasm
Squamous Cell Carcinoma
T Cell Lymphoproliferative Disorder
T Lymphoblastic Leukemia/Lymphoma
T-Cell LGL Leukemia
Thymic Carcinoma
Thymoma
Urothelial Carcinoma
Tumors of Peripheral Nerves
Unknown
Wilms Tumor
Ependymoma, Anaplastic
Astrocytoma, Pilocytic
Ganglioglioma
Neuroepithelial Neoplasm, NOS
Pleomorphic Carcinoma
Solitary Fibrous Tumor
Neuroepithelial neoplasm, high grade
Leukocytosis
Thrombocytosis
Monocytosis
Cytopenia
Other Acute Leukemia
Astrocytoma, NOS
Acute Leukemia of Unspecified Cell Type
Anemia, Unspecified
Astrocytoma, Diffusely Infiltrating
Diffuse Midline Glioma
Infiltrating Glioma, NOS
Intraductal Papillary Mucinous Neoplasm (IPMN)
Leukopenia
Lymphadenopathy
Lymphocytosis, Symptomatic
Monoclonal Gammopathy
Mucinous or Serous Cystic Neoplasms of Pancreas
Mycosis Fungoides, Unspecified Site
Oligodendroglioma, Anaplastic
Pleomorphic Xanthoastrocytoma
Rash and Other Nonspecific Skin Eruption
Thrombocytopenia, Unspecified
Eosinophilia
Myelodysplastic/Myeloproliferative Neoplasm
Myeloid Neoplasm
Polycythemia
Tissue(s)Adrenal Gland
Anus
Ampulla (Pancreaticobiliary Duct)
Appendix
Bladder
Blood
Bone
Bone Marrow
Brain
Breast
Spinal Cord
Cervix
Chest Wall
Colon
Endometrium
Esophagus
Eye
Fallopian Tube
Fibroadipose Tissue
Gall Bladder
Kidney
Larynx
Liver
Lung
Lymph Node
Nasal Cavity
Oral Cavity
Ovary
Pancreas
Parathyroid
Penis
Peripheral Nervous System
Peritoneum
Pharynx
Pituitary
Placenta
Pleura
Prostate
Retroperitoneum
Salivary Gland
Seminal Vesicle
Skeletal Muscle
Skin
Small Intestine
Soft Tissue
Spleen
Stomach
Testis
Thymus
Thyroid
Tonsil
Unknown
Ureter
Uterus
Vagina
Rectum
Cartilage
Blood Vessel
Buccal Swab
Heart
Trachea
Salivary Duct
Spermatic Cord
Vulva
Brain, Infratentorial
Brain, Supratentorial
Gastroesophageal Junction
Sellar
Suprasellar
Peritoneal fluid
Pleural Fluid
Tier2
Interpretation

This gene is a known cancer gene.

Citations

Forbes, Simon A., David Beare, Harry Boutselakis, Sally Bamford, Nidhi Bindal, John Tate, Charlotte G. Cole, et al. "COSMIC: Somatic Cancer Genetics at High-Resolution." Nucleic Acids Research 45, no. D1 (January 4, 2017): D777--83. doi:10.1093/nar/gkw1121.

Disclaimer: You assume full responsibility for all risks associated with using this PMKB website. The IPM makes no guarantee of the comprehensiveness, reliability or accuracy of the information on this website and the IPM assumes no responsibility for errors in the information associated with this web site. Healthcare providers and patients must integrate all clinical and laboratory findings as well as information from a variety of sources before deciding on appropriate clinical care options.

  • Home
  • Browse
  • GGenes
  • VVariants
  • IInterpretations
  • TTumor Types
  • STissues
  • Activity
  • Contact
  • External Links
    • COSMIC
    • My Cancer Genome
    • TumorPortal
    • cBioPortal
    • cBioPortal for IPM
    • UniProt
    • Ensembl
    • PubMed
    • Clinical Trials
    • FDA Pharmacogenetics
    • Exome Variant Server
    • Google

Copyright IPM 2015-2018 - Build v.1.0.05